Lupin Limited has informed the Exchange regarding a press release dated February 06, 2024, titled "Lupin Receives Approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.075%.".
Lupin Limited has informed the Exchange regarding a press release dated February 06, 2024, titled "Lupin Receives Approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.075%.".